AUDIOEYE INC (AEYE)

US0507342014 - Common Stock

18.45  +1.08 (+6.22%)

After market: 18.49 +0.04 (+0.22%)

Fundamental Rating

2

Taking everything into account, AEYE scores 2 out of 10 in our fundamental rating. AEYE was compared to 277 industry peers in the Software industry. AEYE may be in some trouble as it scores bad on both profitability and health. AEYE is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year AEYE has reported negative net income.
In the past year AEYE had a positive cash flow from operations.
In the past 5 years AEYE always reported negative net income.
In the past 5 years AEYE reported 4 times negative operating cash flow.

1.2 Ratios

AEYE's Return On Assets of -23.04% is on the low side compared to the rest of the industry. AEYE is outperformed by 70.44% of its industry peers.
Looking at the Return On Equity, with a value of -87.57%, AEYE is doing worse than 73.36% of the companies in the same industry.
Industry RankSector Rank
ROA -23.04%
ROE -87.57%
ROIC N/A
ROA(3y)-38.15%
ROA(5y)-47.93%
ROE(3y)-89.06%
ROE(5y)-172.85%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of AEYE (77.72%) is better than 75.91% of its industry peers.
AEYE's Gross Margin has improved in the last couple of years.
AEYE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.14%
GM growth 5Y7.74%

2

2. Health

2.1 Basic Checks

AEYE does not have a ROIC to compare to the WACC, probably because it is not profitable.
AEYE has more shares outstanding than it did 1 year ago.
AEYE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AEYE is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 2.61 indicates that AEYE is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.61, AEYE is in line with its industry, outperforming 56.20% of the companies in the same industry.
A Debt/Equity ratio of 1.00 is on the high side and indicates that AEYE has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.00, AEYE is doing worse than 73.72% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z 2.61
ROIC/WACCN/A
WACC9.77%

2.3 Liquidity

A Current Ratio of 1.28 indicates that AEYE should not have too much problems paying its short term obligations.
AEYE's Current ratio of 1.28 is on the low side compared to the rest of the industry. AEYE is outperformed by 63.14% of its industry peers.
AEYE has a Quick Ratio of 1.28. This is a normal value and indicates that AEYE is financially healthy and should not expect problems in meeting its short term obligations.
AEYE has a worse Quick ratio (1.28) than 60.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.28

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 46.74% over the past year.
AEYE shows a small growth in Revenue. In the last year, the Revenue has grown by 4.68%.
AEYE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.80% yearly.
EPS 1Y (TTM)46.74%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q76.47%
Revenue 1Y (TTM)4.68%
Revenue growth 3Y15.21%
Revenue growth 5Y40.8%
Revenue growth Q2Q1.68%

3.2 Future

AEYE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.44% yearly.
Based on estimates for the next years, AEYE will show a quite strong growth in Revenue. The Revenue will grow by 12.04% on average per year.
EPS Next Y59.76%
EPS Next 2Y39.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.08%
Revenue Next 2Y12.04%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

AEYE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AEYE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

AEYE's earnings are expected to grow with 39.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.44%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AEYE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AUDIOEYE INC

NASDAQ:AEYE (5/3/2024, 7:00:00 PM)

After market: 18.49 +0.04 (+0.22%)

18.45

+1.08 (+6.22%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap214.76M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.04%
ROE -87.57%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 77.72%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.28
Quick Ratio 1.28
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)46.74%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y59.76%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4.68%
Revenue growth 3Y15.21%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y